Introduction: The Rising Costs of Medications and Their Impact on Medicare Beneficiaries As we dive into the nitty-gritty of Medicare drug costs, it’s clear that the shift from copayment to coinsurance models in Medicare Part D plans is causing quite a stir. The recent study from the USC Schaeffer Center, published in JAMA, paints a […]
drug costs
High Costs and Efficacy Controversies of New Alzheimer’s Drug Kisunla
The recent approval of a new Alzheimer’s drug by the U.S. Food and Drug Administration (FDA) has sparked a significant conversation about the cost and efficacy of treatments for this debilitating disease. With nearly 7 million Americans suffering from Alzheimer’s, the introduction of Eli Lilly’s new drug, Kisunla, offers a glimmer of hope. However, the […]
